Radcliffe Capital Management’s Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer APSG.WS Stock Holding History

Radcliffe Capital Management’s Portfolio APSG.WS Stock Details APSG.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-150,000	Closed	-$1.49M	–	1300
2022 Q1	$1.49M	Hold	150,000	–	–	0.03%	788
2021 Q4	$1.48M	Sell	150,000 -72,140	-32%	-$75.6K	0.04%	684
2021 Q3	$2.17M	Hold	222,140	–	–	0.06%	443
2021 Q2	$2.17M	Hold	222,140	–	–	0.07%	464
2021 Q1	$2.2M	Buy	+222,140	New	+$430K	0.09%	400

Radcliffe Capital Management's APSG.WS Position: Q2 2022 in Review

Radcliffe Capital Management sold out of Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer (APSG.WS) in Q2 2022, closing a stake of 150,000 shares — an estimated $1.49M sold.

Radcliffe Capital Management first reported a position in APSG.WS in Q1 2021 and held it in 5 quarters. The position peaked at $2.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold APSG.WS as of Q2 2022.

Radcliffe Capital Management reported no remaining Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position as of Q2 2022 after selling out during the quarter.
Radcliffe Capital Management sold 150,000 Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer shares in Q2 2022, an estimated $1.49M.
Radcliffe Capital Management first reported a position in Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer in Q1 2021 and held it in 5 quarters.
Radcliffe Capital Management's Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer position peaked at $2.2M in Q1 2021.
0 funds tracked by Wall St. Rank held Apollo Strategic Growth Capital Warrants, each exercisable for one Class A Ordinary Share at an exer as of Q2 2022.

Based on Radcliffe Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.